Angiodynamics to report fiscal 2023 first quarter financial results on october 6, 2022

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that it will report financial results for the first quarter of fiscal year 2023 before the market open on thursday, october 6, 2022. the company's management will host a conference call at 8:00 a.m. et the sam
ANGO Ratings Summary
ANGO Quant Ranking